LAKE FOREST, Calif., Oct. 20, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, is pleased to introduce to the market the ...

Speclipse, a company specializing in laser and artificial intelligence (AI)-based skin treatment and skin cancer diagnosis, announced on the 27th that ...

InMode has a strong competitive position in the rapidly growing global aesthetic market with its innovative products and technology. The company has achieved impressive financial performance with ...

Shares of InMode (NASDAQ: INMD), a medical technology company focused on the aesthetics industry, recently reached a new 52-week high in anticipation of the second-quarter earnings report the company ...

InMode is a small-cap medical device company that invented a new way to do plastic surgery in a non-invasive way, via radio waves. The company is dominating its niche market, and the stock is up ...

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable ...

InMode is a medical device maker that specializes in minimally invasive treatments with results that resemble those of liposuction. The average price target on Wall Street for InMode represents a 47% ...

InMode Ltd INMD shares are trading lower by over 20% after the company issued Q3 guidance below estimates and lowered FY23 revenue guidance. The company expects Q3 revenue of $122.8 million-$123.0 ...

Sometimes the best opportunities are found in the laggards. Take medical technology (or medtech) stocks, for example. As a group, medtech stocks haven't performed well over the last year. However, ...

We recently compiled a list of the 10 Best Middle East and Africa Stocks To Buy According to Analysts. In this article, we are going to take a look at where InMode (NASDAQ:INMD) stands against the ...

InMode Ltd INMD shares are trading lower Tuesday after the company reported better-than-expected results, but issued a weak earnings forecast. InMode noted that its proprietary surgical technology ...